Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

50%

5 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

86% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (3)

Trial Status

Completed6
Recruiting3
Terminated1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (10)

Research Network

Activity Timeline